['type1 diabetes mellitus']
['biochaperone® insulin lispro', 'fiasp®', 'novorapid®']

        Inclusion Criteria:

          -  Type 1 Diabetes Mellitus for more than 12 months.

          -  BMI between 18.5 and 28.5 kg/m².

          -  HbA1C level <=9.0%.

          -  Insulin treated for at least 12 months with total insulin dose <1.2U/kg/day.

        Exclusion Criteria:

          -  Type 2 Diabetes Mellitus.

          -  History of multiple and/or severe allergies to drugs or foods.

          -  Any history or presence of clinically relevant cardiovascular, pulmonary, respiratory,
             gastrointestinal, hepatic, renal, metabolic, endocrinological (with the exception of
             conditions associated with diabetes mellitus), haematological, dermatological,
             neurological, osteomuscular, articular, psychiatric, systemic, ocular, gynaecologic
             (if female), or infectious disease, or signs of acute illness as judged by the
             Investigator.

          -  More than one episode of severe hypoglycaemia with seizure, coma or requiring
             assistance of another person during the past 6 months.

          -  Proliferative retinopathy or maculopathy and/or severe neuropathy, in particular
             autonomic neuropathy.

          -  Females of childbearing potential, who are pregnant, breast-feeding or intend to
             become pregnant or are not using highly effective contraceptive methods.
      